Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Chronic Obstructive Pulmonary Diseases
What type of disease is chronic obstructive pulmonary disease
Chronic Obstructive Pulmonary Diseases
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Chronic Obstructive Pulmonary Diseases
ut how they do a study on COPD patients ( chronic obstructive pulmonary disease ) which are patients who have a lung disease characterized by chronic obstruction of airflow that interferes with normal breathing and is not fully reversible. Their objective was to use an unsupervised method to analyze the proteomic profile ( the large-scale study of proteins ) of peripheral neutrophils of stable COPD patients and healthy aged matched controls to find differences in the profiles . The researchers performed fluorescence ( emit visible light when they irradiated with ultraviolet rays or with violet-blue visible light ) two-dimensional difference gel-electrophoresis ( process in which molecules such as proteins , DNA , or RNA fragments can be separated …show more content…
according to size and electrical charge by applying an electric current to them while they are in a gel ) with undergo of peripheral neutrophils of stable COPD patients and controls . Their results when they identified the two groups based on the differentially regulated proteins and hierarchical clustering was that there was no difference in lung function between the two different groups .
Although the neutrophils from one of the COPD groups was less responsive to bacterial peptide . This shows that systemic inflammatory signals do not necessarily correspond with the GOLD classification and that inflammatory phenotyping can remarkably add in enhanced diagnosis of single COPD patients . The background is that COPD as i stated earlier is characterized by irreversible airflow limitation , and is a leading cause of mortality and morbidity . Cigarettes as stated in the article is the most important risk factor for the development of chronic obstructive pulmonary disease in the western world . According to GOLD the diagnosis and severity of COPD is assessed using lung function measurements , like FEV1 , FVC . It is well received that these spirometry measurements are insufficient , mainly because spirometry data alone poorly correlate with symptoms and health status . A lot of studies have focused on the identification of disease phenotype in COPD , and have also searched for individual and/or combined biomarkers using the data they collected
. They couldn’t do invasive procedures , because they are difficult to do regularly on COPD patients . There is an unmet clinical need for objective disease markers identifying COPD phenotype that can be obtained with non-invasive methods . The airflow limitation in COPD is usually progressive and is related with an abnormal inflammatory response in the lungs . The inflammation in the lungs is characterized by a buildup of neutrophils , macrophages and lymphocytes .
The presented case is of a patient named R.S. who has a smoking history of many years, which can be directly tied to his development of chronic bronchitis, a chronic obstructive pulmonary disease (COPD) specified as Type B. It is estimated that in 90% of chronic bronchitis or “blue bloaters”, cigarette smoking is the major cause. Chronic bronchitis involves persistent and irreversible airway obstruction, due to the constant inflammation of the bronchial mucosa, leading to hypertrophy and hyperplasia of bronchial glands. The latter exposes the individual to higher risks of bacterial infections; often colonization of organisms such as Streptococcus or Staphyloccocus pneumoniae can be exhibited. This is due to the lost or impaired function of mucociliary clearance action which results from the replacement of certain sections of ciliated columnar epithelium by squamous cells in the bronchi. (Copstead &Banasik, 546-547)
65year old male Bill Mc Donald a current smoker, presents from home with a chronic productive cough, increase shortness of breath at rest, wheezing and increase in lethargy. Bill has a past medical history of chronic obstructed airway disease, recurrent bronchial infections and current pack a day smoker.
Mrs. Jones has a history of COPD. She was already taking albuterol for her illness and it was ineffective when she took it that day. Mrs. Jones had been a smoker but had quit several years ago. According to Chojnowski (2003), smoking is a major causative factor in the development of COPD. Mrs. Jones's primary provider stated that she had a mixed type of COPD. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) was established to address the growing problem of COPD. The GOLD standards identify three conditions that contribute to the structural changes found in COPD: Chronic bronchiolitis, emphysema, and chronic bronchitis. A mixed diagnosis means that the patient has a combination of these conditions (D., Chojnowski, 2003). Mrs. Jones chronically displayed the characteristic symptoms of COPD. "The characteristic symptoms are cough, sputum production, dyspnea on exertion, and decreased exercise tolerance." (D., Chojnowski, 2003, p. 27).
This meant that this cuvette (tested under light) should display a higher decrease in DCIP due to the reduction in absorbance (dependent variable) opposed to the other cell fractions tested depending on a sixteen minute period (independent variable). The overall goal was to provide proof, through data, that the cell fractions put under the light during the sixteen minute period would indicate a higher set of chloroplast activity versus the ones put in the
CF multi-disciplinary team also undertakes clinical research of the condition, where new treatment and therapies are constantly exploring, becoming more effective. In the clinic whilst the patients wait to be seen by medical staff, they were often asked to complete a questionnaire or to participate in the studies. Some patients volunteered to take part in a clinical trial such as a Kalydeco trial.
Chronic obstructive pulmonary disease or COPD is a group of progressive lung diseases that block airflow and make it hard to breathe. Emphysema and chronic bronchitis are the most common types of COPD (Ignatavicius & Workman, 2016, p 557). Primary symptoms include coughing, mucus, chest pain, shortness of breath, and wheezing (Ignatavicius & Workman, 2016, p.557). COPD develops slowly and worsens over time if not treated during early stages. The disease has no cure, but medication and disease management can slow its progress and make one feel better (NIH, 2013)
The purpose of this essay is to explore nursing care priorities for a patient with a common health condition. A common health condition is a disease or condition which occurs most often within a population. The author has chosen scenario 3 for this essay and will describe the nursing assessment and care planning provided to a patient with Chronic Obstructive Pulmonary Disease (COPD). The WHO definition of COPD is a lung disease which has a chronic obstruction of the airways that impedes normal breathing and is not fully reversible (). According to), there are estimated to be over 3 million people in the UK with COPD. It is common in later life and there are approximately 25,000 deaths each year, with 15% of COPD being work related (The identity of the patient will remain anonymous in adherence with the Nursing and Midwifery Council, Code of Conduct on patient confidentiality (). However, the patient will be referred to as Mr B in this essay. The author has chosen the priority of eating and drinking for Mr B. Patients with COPD are at increased risk of malnutrition and nurses must make certain they screen patients and offer advice or refer as necessary (). If this priority is managed well it will have a positive effect on the other priorities (, 2012). In accordance with NICE Guideline 101 (), the treatment and care provided should consider each persons’ individual requirements and preference. Care and treatment should take into account people’s individual needs and choices. To allow people to reach informed decisions there must be good communication, supported by evidence-based practice (). This essay will provide an evidence based discussion on how care will be implemented in relation to Mr B and his eating and drin...
The EB’s case study said the female patient is 50 years old with symptoms of fever, chills, congestion, three weeks of coughing, shortness of breath when walking. The study implies that the patient is now seeking medical advice due to vital signs recording and the noting of decreased breath sounds and wheezing. She denies smoking and not taking any chronic medication.
Carone M, D. C. ( 2007). Clinical Challenges In COPD[e-book]. (Oxford: Clinical Pub) Retrieved March 24, 2014, from (EBSCOhost).
... susceptibility. Patients who subsequently needed further treatment for coronary heart disease displayed significantly different protein expression as opposed to patients who needed no further treatment. This revolutionary study provides a new way of detecting coronary artery disease that is both cost effective and less dangerous for patients.
Chronic obstructive pulmonary disease (COPD) is preventable disease that has a detrimental effects on both the airway and lung parenchyma (Nazir & Erbland, 2009). COPD categorises emphysema and chronic bronchitis, both of which are characterised by a reduced maximum expiratory flow and slow but forced emptying of the lungs (Jeffery 1998). The disease has the one of the highest number of fatalities in the developed world due to the ever increasing amount of tobacco smokers and is associated with significant morbidity and mortality (Marx, Hockberger & Walls, 2014). Signs and symptoms that indicate the presence of the disease include a productive cough, wheezing, dyspnoea and predisposing risk factors (Edelman et al., 1992). The diagnosis of COPD is predominantly based on the results of a lung function assessment (Larsson, 2007). Chronic bronchitis is differentiated from emphysema by it's presentation of a productive cough present for a minimum of three months in two consecutive years that cannot be attributed to other pulmonary or cardiac causes (Marx, Hockberger & Walls, 2014) (Viegi et al., 2007). Whereas emphysema is defined pathologically as as the irreversible destruction without obvious fibrosis of the lung alveoli (Marx, Hockberger & Walls, 2014) (Veigi et al., 2007).It is common for emphysema and chronic bronchitis to be diagnosed concurrently owing to the similarities between the diseases (Marx, Hockberger & Walls, 2014).
Vijayan, V. K. (2013). Chronic obstructive pulmonary disease. Indian Journal Of Medical Research, 137(2), 251-269.
Parker, Steve. "Chronic Pulmonary Diseases." The Human Body Book. New ed. New York: DK Pub., 2007.
There are several important tests used by healthcare providers to determine whether an obstructive or restrictive lung disease is present. The term used to group these procedures is Pulmonary Function Tests, also called PFTs, and they do more than just determine the type of lung disease that may be present but can also provide answers as to where the problem is located as well. The term PFTs refers to a variation of different pulmonary testing that can be performed by healthcare professionals that help to give insight as to how well an individual's lungs are working. Some of these tests, such as spirometry and lung volumes provide this information by measuring airflow and lung capacity. Others such as diffusion capacity and the arterial blood
Sharing certain aspects of practice with other disciplines of pathology like clinical pathology, anatomic pathology, biochemistry, and molecular biology, molecular pathology seeks to understand and diagnose, at a molecular level, the mechanisms and origins of diseases (Harris and McCormick 2010). Through patient samples tests are carried out to measure